Make your money go further for just 25p per day

AIM’s innovators join the January sell-off

01/02/2022 · Cambridge Cognition (COG)  · Creo Medical Group PLC (CREO) 

AIM Innovators UK

Bear market sell-off chart
  • The AIM All Share ended January down 10% with pharma and tech stocks selling off especially heavily
  • The long-term outlook for these sectors continues to be positive

Predicting the end of easy money has been a pastime of doom-mongers’ for at least five years. January 2022 therefore provided ample opportunity for these pessimists to make sweeping statements as interest rate worries weighed heavily on growth stocks and share global indices crashed downwards. “We enter 2022 amid the most extreme financial bubble in US history,” said John Hussman, which will allow him to add 2022 to the list of market crashes he has…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Cambridge Cognition

Excellent results and an exciting future

12/04/2022 · Company Insights

This digital health technology company developing solutions to assess brain health, has announced excellent full year results. Upgraded forecasts…


Victoriana going cheap

29/03/2022 · Company Insights

An entertainment business covered here, with its roots in the Victorian era, has just reported encouraging…


More on Creo Medical Group PLC

Good day for the AIM innovators

04/02/2022 · Company Insights

Contract awards and an encouraging trading update saw shares in two AIM innovators covered here rise…


AIM’s innovators join the January sell-off

01/02/2022 · Company Insights

Sign-up to our free email updates

SIGN UP